论文信息 - Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016) - 字舞流文

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)

D. Reinke | C. Meyer | L. Helman | A. Hirbe | B. Widemann | E. Dombi | J. Perentesis | M. Milhem | S. Okuno | K. Cichowski | N. Jayaprakash | R. Chugh | B. Turpin | A. Kim | J. Pressey | G. Cote | Yao Lu | Ndidi Onwudiwe | AeRang Kim